Dishman Pharma - Q4FY12 Result update - Centrum - Equity Bulls

Dishman Pharma - Q4FY12 Result update - Centrum Equity Bulls The company is likely to benefit from anti-cancer, vitamin D3 and disinfectant facilities going on stream during the quarter. We have retained Buy rating for the scrip with a target price of Rs72 (based on 25x FY14E EPS of Rs14.4).

Vital Savings on Vitamins - DailyFinance

Vital Savings on Vitamins DailyFinance An apple a day may keep the doctor away, but a daily multivitamin can go a long way, too. Do you want to stay fit and frugal? Here are a few ways you can do so without wiping out your wallet. A 200-count bottle of Centrum is priced at $13.00, ...

Some vitamins, supplements are a waste of money - CTV.ca

Some vitamins, supplements are a waste of money CTV.ca More than half of us take vitamins and supplements regularly, but while some have proven benefits, others are a total waste of money. Calcium combined with vitamin D is known to benefit bones, and it's among the supplements worth considering, ...